Marco Pisa, Joseph L Watson, Jonathan I Spencer, Guy Niblett, Yasamin Mahjoub, Andrew Lockhart, Richard L Yates, Sydney A Yee, Gina Hadley, Jennifer Ruiz, Margaret M Esiri, Benedict Kessler, Roman Fischer, Gabriele C DeLuca
Multiple sclerosis (MS) is unsurpassed for its clinical and pathological hetherogeneity, but the biological determinants of this variability are unknown. HLA-DRB1*15, the main genetic risk factor for MS, influences the severity and distribution of MS pathology. This study set out to unravel the molecular determinants of the heterogeneity of MS pathology in relation to HLA-DRB1*15 status. Shotgun proteomics from a discovery cohort of MS spinal cord samples segregated by HLA-DRB*15 status revealed overexpression of the extracellular matrix (ECM) proteins, biglycan, decorin, and prolargin in HLA-DRB*15-positive cases, adding to established literature on a role of ECM proteins in MS pathology that has heretofore lacked systematic pathological validation...
April 25, 2024: Brain Pathology